Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.

Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.

Item
http://www.wikidata.org/entity/Q33852361
Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination StrategiesWhich Antibody Functions are Important for an HIV Vaccine?Neutralizing antibodies inhibit HIV-1 infection of plasmacytoid dendritic cells by an FcγRIIa independent mechanism and do not diminish cytokines production.A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremiaEfficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions.Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway.Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy.
P2860

Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.

Item
http://www.wikidata.org/entity/Q33852361
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunoglobulin G (IgG) and IgA ...... asma of HIV-infected patients.
@ast
Immunoglobulin G (IgG) and IgA ...... asma of HIV-infected patients.
@en
type
label
Immunoglobulin G (IgG) and IgA ...... asma of HIV-infected patients.
@ast
Immunoglobulin G (IgG) and IgA ...... asma of HIV-infected patients.
@en
prefLabel
Immunoglobulin G (IgG) and IgA ...... asma of HIV-infected patients.
@ast
Immunoglobulin G (IgG) and IgA ...... asma of HIV-infected patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Immunoglobulin G (IgG) and IgA ...... asma of HIV-infected patients.
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.75.11.5421-5424.2001
P433
P478
P50
P577
P698
P932